首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Model development for determining the efficacy of a combination coating for the prevention of perioperative device related infections: A pilot study
【24h】

Model development for determining the efficacy of a combination coating for the prevention of perioperative device related infections: A pilot study

机译:用于确定组合涂层用于预防围手术装置相关感染的疗效的模型开发:试验研究

获取原文
获取原文并翻译 | 示例

摘要

Antibiotic resistant bacterial infections are a growing problem in patient care. These infections are difficult to treat and severely affect the patient's quality of life. The goal of this translational experiment was to investigate the antimicrobial potential of cationic steroidal antimicrobial-13 (CSA-13) for the prevention of perioperative device-related infections in vivo. It was hypothesized that when incorporated into a polymeric device coating, the release of CSA-13 could prevent perioperative device-related infection without inhibiting skeletal attachment. To test this hypothesis, 12 skeletally mature sheep received a porous coated titanium implant in the right femoral condyle. Group 1 received the titanium implant and an inoculum of 5 x 10(8) CFU of methicillin-resistant Staphylococcus aureus (MRSA). Group 2 received a CSA-13 coated implant and the MRSA inoculum. Group 3 received only the CSA-13 coated implant and Group 4 received only the implantwithout the CSA-13 coating or MRSA inoculum. In conclusion, the CSA-13 combination coating demonstrated bactericidal potential without adversely affecting skeletal attachment. The CSA-13 containing groups exhibited no evidence of bacterial infection at the conclusion of the 12 week study and established skeletal attachment consistent with Group 4. In contrast, all of the Group 1 animals became infected and required euthanasia within 6-10 days. The significance of this finding is that this combination coating could be applied to implanted devices to prevent perioperative device-related infections. This method may facilitate significantly reduced incidences of device-related infections as well as a new method to treat and prevent resistant strain bacterial infections. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 101B: 1143-1153, 2013.
机译:抗生素抗性细菌感染是患者护理的不断增长的问题。这些感染难以治疗和严重影响患者的生活质量。该转化实验的目的是探讨阳离子甾体抗微生物-13(CSA-13)的抗微生物潜力,用于预防体内围手术期有关的感染。假设,当掺入聚合物器件涂层中时,CSA-13的释放可以防止围手术期有关的感染而不抑制骨骼连接。为了测试这个假设,12个骨骼成熟的绵羊在右股骨髁上接受多孔涂层钛植入物。第1组接收钛植入物和含有5×10(8)个CFU的甲氧西林金黄色葡萄球菌(MRSA)的接种物。第2组接受CSA-13涂层植入物和MRSA接种物。第3组仅接收CSA-13涂覆植入物,第4组仅接受了CSA-13涂层或MRSA接种物的植入术。总之,CSA-13组合涂层显示杀菌潜力,而不会对骨骼连接不利影响。含CSA-13的组在12周的研究结束时没有表现出细菌感染的证据,并建立了与第4组一致的骨骼连接。相反,所有组1只动物在6-10天内被感染和需要安乐死。该发现的重要性是该组合涂层可以应用于植入装置以防止围手术期有关的感染。该方法可以促进有关设备相关感染的显着降低的发病率以及治疗和防止抗性菌株细菌感染的新方法。 (c)2013 Wiley期刊,Inc。J生物保解率B:苹果生物粉末101B:1143-1153,2013。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号